Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Ordinary Shares, par value $0.01 per share
-
Shares outstanding
-
39,031,509
-
Total 13F shares
-
10,313,801
-
Share change
-
-10,911
-
Total reported value
-
$75,218,046
-
Price per share
-
$7.29
-
Number of holders
-
44
-
Value change
-
-$870,603
-
Number of buys
-
19
-
Number of sells
-
20
Institutional Holders of Keenova Therapeutics plc - Ordinary Shares, par value $0.01 per share (MNKTQ) as of Q1 2023
As of 31 Mar 2023,
Keenova Therapeutics plc - Ordinary Shares, par value $0.01 per share (MNKTQ) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,313,801 shares.
The largest 10 holders included
Bracebridge Capital, LLC, JPMORGAN CHASE & CO, Hudson Bay Capital Management LP, Alta Fundamental Advisers LLC, FEDERATED HERMES, INC., Sculptor Capital LP, VANGUARD GROUP INC, NOMURA HOLDINGS INC, GOLDMAN SACHS GROUP INC, and STIFEL FINANCIAL CORP.
This page lists
44
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.